U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828107) titled 'A Study to Evaluate the SENSE Device's Ability to Detect TBI' on Feb. 10.
Brief Summary: The study population will consist of 3 mutually-exclusive sets of patients and subjects:
* TBI patients with intracranial bleeding
* TBI patients without intracranial bleeding
* Control subjects with normal brain health.
Research subjects ages 22 and older will be enrolled. All TBI patients must be monitored with the SENSE Device within 6 hours of a diagnostic head CT scan ordered by a treating clinician and within 24 hours of injury.
Study Start Date: June 01, 2025
Study Type: OBSERVATIONAL
Condition:
Traumatic Brain Injury
Interventio...